Defining secondary progressive multiple sclerosis
Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis, Tim Spelman, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Marc Girard, Pierre Duquette, Alexandre Prat, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Raymond Hupperts, Raed Alroughani, Patrizia Sola, Cavit Boz, Eugenio Pucci, Jeanette Lechner-Scott Show all
BRAIN | OXFORD UNIV PRESS | Published : 2016
Related Projects (4)
Awarded by National Health and Medical Research Council
This study was financially supported by the National Health and Medical Research Council (practitioner fellowship 1080518, project grants 1083539 and 1032484 and centre for research excellence 1001216), the University of Melbourne (Faculty of Medicine, Dentistry and Health Sciences research fellowship) and Biogen (Fellowship in MS Registries Research). The MSBase Foundation is a not-for-profit organization that receives support from Merck, Biogen, Novartis, Bayer-Schering, Genzyme, Teva and Sanofi-Aventis. The study was conducted separately and apart from the guidance of the sponsors.